Crebinostat

Crebinostat is a histone deacetylase (HDAC) inhibitor and possible cognitive enhancer.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Crebinostat is a histone deacetylase (HDAC) inhibitor and possible cognitive enhancer.

Pharmacology

Crebinostat is a histone deacetylase (HDAC) inhibitor, specifically inhibiting the class I HDAC1, HDAC2, and HDAC3, the class IIb HDAC6, and weakly the class I HDAC8, with no significant inhibition of the class IIa HDAC4, HDAC5, HDAC7, or HDAC9. The drug has been found to robustly activate CREB-mediated transcription and to upregulate brain-derived neurotrophic factor (BDNF) expression and increase synaptogenesis.

It has been found to enhance memory in rodents. The pharmacokinetics of crebinostat have been studied in rodents.

Chemistry

The chemical synthesis of crebinostat has been described. A notable analogue of crebinostat is neurinostat.

History

Crebinostat was first described in the scientific literature by 2013. It was identified via screening of a library of over 1,200 compounds designed to target HDACs. There is interest in crebinostat as a potential novel cognitive enhancer in humans. Subsequent to the development of crebinostat, an analogue known as neurinostat with improved properties was discovered and described.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1367412096 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.